Cytokeratin 18 Polyclonal Antibody and 2 more items

Life Technologies Corporation was awarded contract A207_PO-0453099 by the University of Virginia in Virginia on June 26, 2026, with a cumulative contract value of $1,096.04. The contract encompasses the delivery of three distinct biochemical product lines to be delivered to Nicholas Maximilian Hagspiel. The primary deliverables include one unit of Cytokeratin 18 Polyclonal Antibody at a unit price of $429.00, two units of Sulfo-NHS (N-hydroxysulfosuccinimide) in No-Weigh Format (10 x 2 mg) at $171.60 per unit, and two units of Pierce EDC (1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide) in No-Weigh Format (10 x 1 mg) at $161.92 per unit.

These reagent products represent standard laboratory consumables typically utilized in protein analysis, immunoassay development, and cross-linking applications within research settings. The Cytokeratin 18 Polyclonal Antibody serves diagnostic and research applications in cellular biology, while the Sulfo-NHS and Pierce EDC compounds function as chemical linkers and coupling reagents commonly employed in protein modification and conjugation protocols. The contract award reflects routine procurement of specialized scientific materials by an academic research institution from an established life sciences supplier.